KR970074753A - 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제 - Google Patents

치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제 Download PDF

Info

Publication number
KR970074753A
KR970074753A KR1019970021106A KR19970021106A KR970074753A KR 970074753 A KR970074753 A KR 970074753A KR 1019970021106 A KR1019970021106 A KR 1019970021106A KR 19970021106 A KR19970021106 A KR 19970021106A KR 970074753 A KR970074753 A KR 970074753A
Authority
KR
South Korea
Prior art keywords
carbon atoms
alkyl
compound
formula
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019970021106A
Other languages
English (en)
Korean (ko)
Inventor
요아힘 브렌델
하인츠-베르너 클레만
하인리히 크리스티안 엔글레르트
한스 요헨 랑
우도 알부스
반지 랄
아닐 바산트라오 가트
Original Assignee
로제르트, 피셔
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로제르트, 피셔, 훽스트 아크티엔게젤샤프트 filed Critical 로제르트, 피셔
Publication of KR970074753A publication Critical patent/KR970074753A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019970021106A 1996-05-29 1997-05-28 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제 Ceased KR970074753A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19621482.3 1996-05-29
DE19621482A DE19621482A1 (de) 1996-05-29 1996-05-29 Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
KR970074753A true KR970074753A (ko) 1997-12-10

Family

ID=7795548

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970021106A Ceased KR970074753A (ko) 1996-05-29 1997-05-28 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제

Country Status (29)

Country Link
US (1) US6600072B2 (enExample)
EP (1) EP0810205B1 (enExample)
JP (1) JP4039587B2 (enExample)
KR (1) KR970074753A (enExample)
CN (1) CN1062859C (enExample)
AR (1) AR007299A1 (enExample)
AT (1) ATE200076T1 (enExample)
AU (1) AU710258B2 (enExample)
BR (1) BR9703342A (enExample)
CA (1) CA2206362C (enExample)
CZ (1) CZ292441B6 (enExample)
DE (2) DE19621482A1 (enExample)
DK (1) DK0810205T3 (enExample)
ES (1) ES2155223T3 (enExample)
GR (1) GR3035811T3 (enExample)
HR (1) HRP970294B1 (enExample)
HU (1) HUP9700954A3 (enExample)
ID (1) ID17348A (enExample)
IL (1) IL120925A0 (enExample)
NO (1) NO308528B1 (enExample)
NZ (1) NZ314914A (enExample)
PL (1) PL185755B1 (enExample)
PT (1) PT810205E (enExample)
RU (1) RU2182901C2 (enExample)
SI (1) SI0810205T1 (enExample)
SK (1) SK282356B6 (enExample)
TR (1) TR199700427A2 (enExample)
TW (1) TW372955B (enExample)
ZA (1) ZA974664B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
AU2003297629A1 (en) 2002-12-04 2004-06-23 Ore Pharmaceuticals Inc. Modulators of melanocortin receptor
JP5030587B2 (ja) * 2003-06-26 2012-09-19 バイオトロン・リミテッド 抗ウイルスアシルグアニジン化合物および方法
EP2321274A1 (en) * 2008-07-08 2011-05-18 Boehringer Ingelheim International GmbH Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251545A (en) * 1979-09-19 1981-02-17 Gaf Corporation Fungicidal process using 1-(alkoxyaroyl)guanidines
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH08225513A (ja) * 1994-12-21 1996-09-03 Kanebo Ltd ナフトイルグアニジン誘導体
JPH08225135A (ja) 1995-02-21 1996-09-03 Mitsubishi Heavy Ind Ltd スクリユ−式土砂搬送機
DE19621483A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CN1167758A (zh) 1997-12-17
ZA974664B (en) 1997-12-01
MX9703921A (es) 1997-11-29
BR9703342A (pt) 1998-08-18
NO972434L (no) 1997-12-01
CA2206362A1 (en) 1997-11-29
SK66997A3 (en) 1997-12-10
DE19621482A1 (de) 1997-12-04
HRP970294A2 (en) 1998-04-30
PL318724A1 (en) 1997-12-08
HUP9700954A2 (hu) 1998-03-02
JP4039587B2 (ja) 2008-01-30
US6600072B2 (en) 2003-07-29
ES2155223T3 (es) 2001-05-01
RU2182901C2 (ru) 2002-05-27
HUP9700954A3 (en) 1998-04-28
HU9700954D0 (en) 1997-07-28
NZ314914A (en) 1998-02-26
CA2206362C (en) 2007-11-20
ID17348A (id) 1997-12-24
PL185755B1 (pl) 2003-07-31
TW372955B (en) 1999-11-01
HRP970294B1 (en) 2002-02-28
AU710258B2 (en) 1999-09-16
SI0810205T1 (enExample) 2001-06-30
CZ292441B6 (cs) 2003-09-17
ATE200076T1 (de) 2001-04-15
DE59703220D1 (de) 2001-05-03
NO308528B1 (no) 2000-09-25
NO972434D0 (no) 1997-05-28
TR199700427A2 (xx) 1997-12-21
AR007299A1 (es) 1999-10-27
JPH1081663A (ja) 1998-03-31
DK0810205T3 (da) 2001-07-16
CZ163197A3 (cs) 1998-06-17
CN1062859C (zh) 2001-03-07
IL120925A0 (en) 1997-09-30
US20030013760A1 (en) 2003-01-16
GR3035811T3 (en) 2001-07-31
AU2371397A (en) 1997-12-04
EP0810205B1 (de) 2001-03-28
PT810205E (pt) 2001-08-30
SK282356B6 (sk) 2002-01-07
EP0810205A1 (de) 1997-12-03

Similar Documents

Publication Publication Date Title
RU2003111462A (ru) Замещенные гуанидиды коричной кислоты, способ их получения, их применение в качестве лекарственного средства, а также содержащее их лекарственное средство
KR950005817A (ko) 5원환을 갖는 벤조-융합된 헤테로사이클릭 화합물, 이의 제조방법, 약제로서의 이의 용도, 진단제로서의 이의 용도 및 이를 함유하는 약제
KR970025611A (ko) 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU2000127751A (ru) Противоопухолевое средство
CA2301842A1 (en) Substituted benzene compounds as antiproliferative and cholesterol lowering agents
RU2002106503A (ru) Способ лечения заболеваний, опосредованных опиоидными рецепторами
KR960000861A (ko) 퍼플루오로알킬 그룹을 갖는 페닐-치환된 알케닐카보구아니디드, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU97114306A (ru) Фенилзамещенные гуанидины алкенилкарбоновой кислоты, способ их получения, их применение в качестве лекарственного или диагностического средства, а также содержащее их лекарственное средство
KR970074776A (ko) 치환된 2-나프토일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU95117068A (ru) Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
NZ190859A (en) N-(3-phenylpropyl)-2-hydroxy-2-phenylethylamine derivatives;pharmaceutical compositions
JPH1081664A5 (enExample)
KR970074753A (ko) 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제
KR960041152A (ko) 플루오로페닐-치환된 알케닐카복실산 구아니디드, 이의 제조 방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU97109003A (ru) Замещенные 2-нафтоилгуанидины, способ их получения и лекарственное средство на их основе
KR950032129A (ko) 치환된 비사이클릭의 헤테로아로일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU96101173A (ru) Производные пиридазинонов
KR970006282A (ko) 4-플루오로알킬-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도, 및 이를 포함하는 약제
KR910004559A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체
JPH1081663A5 (enExample)
RU97109002A (ru) Замещенные 1-нафтоилгуанидины, способ их получения и лекарственное средство на их основе
KR970061887A (ko) 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제
RU97108129A (ru) Нитробензамиды, применимые в качестве антиаритмических средств
RU96115324A (ru) Бензоилгуанидины, способ их получения, содержащее их лекарственное или диагностическое средства, способ его получения, способ лечения и профилактики сердечных заболеваний

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19970528

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20020527

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19970528

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20041030

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20050228

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20041030

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I